Cadence Capital Management’s Surmodics SRDX Stock Holding History

Cadence Capital Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-49,659	Closed	-$2.35M	–	458
2018 Q4	$2.35M	Buy	+49,659	New	+$2.98M	0.24%	117
2017 Q2	–	Sell	-20,597	Closed	-$495K	–	694
2017 Q1	$495K	Buy	20,597 +876	+4%	+$21.5K	0.03%	521
2016 Q4	$501K	Sell	19,721 -10,616	-35%	-$279K	0.04%	505
2016 Q3	$913K	Sell	30,337 -202	-0.7%	-$5.55K	0.07%	339
2016 Q2	$717K	Sell	30,539 -601	-2%	-$13.2K	0.05%	377
2016 Q1	$573K	Hold	31,140	–	–	0.04%	445
2015 Q4	$631K	Sell	31,140 -1,880	-6%	-$39.9K	0.04%	428
2015 Q3	$721K	Sell	33,020 -9,973	-23%	-$234K	0.05%	386
2015 Q2	$1.01M	Buy	+42,993	New	+$1.08M	0.06%	423
2013 Q4	–	Sell	-41,012	Closed	-$975K	–	645
2013 Q3	$975K	Sell	41,012 -8,403	-17%	-$180K	0.03%	445
2013 Q2	$989K	Buy	+49,415	New	+$1.24M	0.05%	311

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Cadence Capital Management's SRDX Position: Q1 2019 in Review

Cadence Capital Management sold out of Surmodics (SRDX) in Q1 2019, closing a stake of 49,659 shares — an estimated $2.35M sold.

Cadence Capital Management first reported a position in SRDX in Q2 2013 and held it in 11 quarters. The position peaked at $2.35M in Q4 2018. 151 funds tracked by Wall St. Rank hold SRDX as of Q1 2019.

Cadence Capital Management reported no remaining Surmodics position as of Q1 2019 after selling out during the quarter.
Cadence Capital Management sold 49,659 Surmodics shares in Q1 2019, an estimated $2.35M.
Cadence Capital Management first reported a position in Surmodics in Q2 2013 and held it in 11 quarters.
Cadence Capital Management's Surmodics position peaked at $2.35M in Q4 2018.
151 funds tracked by Wall St. Rank held Surmodics as of Q1 2019.

Based on Cadence Capital Management's 13F filing for Q1 2019, filed 7 May 2019.